Disposable Energy Sources and Operating Room Time for Laparoscopic Hysterectomy
Primary Purpose
Benign Uterine Disease
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
disposable device (Ligasure, Covidien)
Reusable device
Sponsored by
About this trial
This is an interventional treatment trial for Benign Uterine Disease focused on measuring lap hysterectomy, Women in need of a lap hysterectomy for benign disease.
Eligibility Criteria
Inclusion Criteria:
- Age 21 to 80 years of age
- Scheduled for laparoscopic hysterectomy (prospectively)
Exclusion Criteria:
- Under 21 years of age
- Known or anticipated malignancy
Sites / Locations
- Saint Louis University
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Other
Arm Label
Disposable Device - Left & Reusable Devices - Right
Disposable Device - Right & Reusable Devices - Left
Arm Description
One side of the uterine attachments would be transected using the disposable device (Ligasure, Covidien).
One side of the uterine attachments would be transected using the reusable Robi bipolar and Storz laparoscopic
Outcomes
Primary Outcome Measures
The Primary Endpoint of This Study is Time Difference Between Cauterizing One Side of the Uterine Attachments, From the Round Ligament to the Uterine Artery on One Side, to the Time Detaching the Same Tissues on the Other Side
duration of surgery
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02065453
Brief Title
Disposable Energy Sources and Operating Room Time for Laparoscopic Hysterectomy
Official Title
Disposable Energy Sources and Operating Room Time for Laparoscopic Hysterectomy
Study Type
Interventional
2. Study Status
Record Verification Date
May 2017
Overall Recruitment Status
Completed
Study Start Date
January 2012 (undefined)
Primary Completion Date
January 2014 (Actual)
Study Completion Date
January 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
St. Louis University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Over 600,000 hysterectomies are performed each year nationwide. Over 99% of these are accomplished laparoscopically in the investigators current surgical practice to allow women a quicker recovery than a traditional large incision. Disposable laparoscopic devices have been developed to assist in the completion of hysterectomies. These disposable energy sources are only used once, but offer an improved safety and energy profile in that they reliably control bleeding with little damage to surrounding tissue and potentially save time. Reusable energy instruments can be sterilized and reused for multiple cases. Operating room time is expensive. The investigators calculate that if 6.7 minutes of time can be saved using the disposable device, Ligasure (Covidien), versus the reusable Robi bipolar and Storz Laparoscopic Shears, the time savings could justify the cost of the device.
Detailed Description
This will be a randomized, prospective study. The investigators study design would have each patient serve as their own control. One side of the uterine attachments would be transected using the disposable device, Ligasure (Covidien), and the other using the two reusable devices (Robi bipolar and Storz laparoscopic shears). It is the investigators standard practice that the attending surgeon is on the patient's left side while the resident physician is on the patients right. To eliminate the bias of surgical experience, the investigators will randomize the energy source used on each side for every case. Therefore, the number of cases performed by the attending surgeon with the disposable or reusable energy sources, will equal that of the less experienced resident surgeon.
The primary endpoint of this study would be the time difference between cauterizing one side of the uterine attachments, from the round ligament to the uterine artery on one side, to the time detaching the same tissues on the other side. The vesico-uterine peritoneum or "bladder flap", will always be transected from the left for consistency. Sealed, opaque envelopes will be randomized to determine which side of the uterus will get the single disposable instrument, and which will get the 2 reusable instruments.
A time savings of 6.7 minutes for the total case can also be explained by a 3.35 minute time savings PER SIDE of the uterine attachments, given each uterus has two "sides". There is no pre-existing data on time needed for coagulation and cutting of the vascular tissues. Based on experience, the investigators estimate that it takes on average about 20 min total time for vessel sealing, with an estimated variability that approximately 70% of the time, vessel sealing is done within 35 minutes. Given these estimates, and using a power of 0.8, the sample size needed is 45.
The primary endpoint of surgical time will be initially assessed for each individual patient by determining the difference between the half of the laparoscopic hysterectomy procedure performed with the disposable device, specifically the Ligasure (Covidien) and the half of the laparoscopic hysterectomy procedure performed with the two reusable devices (Robi Bipolar and Storz laparoscopic shears) and determining if the mean difference score summed across all patients differs significantly from zero. Subsequent analyses will examine surgical times for attending physicians and residents separately where those using the disposable device are compared to those using the two reusable devices with independent students t test or the Kolmogorov-Smirnov test depending on the normality of the distributions. Parallel analyses will be performed for the secondary endpoint of estimated blood loss. Secondary endpoints of organ damage and other categorical intraoperative complications will be compared between the disposable and reusable device groups using chi-square and Fisher's Exact test.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Benign Uterine Disease
Keywords
lap hysterectomy, Women in need of a lap hysterectomy for benign disease.
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
52 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Disposable Device - Left & Reusable Devices - Right
Arm Type
Other
Arm Description
One side of the uterine attachments would be transected using the disposable device (Ligasure, Covidien).
Arm Title
Disposable Device - Right & Reusable Devices - Left
Arm Type
Other
Arm Description
One side of the uterine attachments would be transected using the reusable Robi bipolar and Storz laparoscopic
Intervention Type
Device
Intervention Name(s)
disposable device (Ligasure, Covidien)
Other Intervention Name(s)
disposable device (Ligasure made by Covidien).
Intervention Description
One side of the uterine attachments would be transected using the disposable device (Ligasure, Covidien). . We will randomize the side for each energy source used on each side for every case. The number of "sides" performed by the attending surgeon will equal that of the less experienced resident surgeon.
Intervention Type
Device
Intervention Name(s)
Reusable device
Other Intervention Name(s)
Robi bipolar and Storz laparoscopic
Intervention Description
One side of the uterine attachments would be transected using the reusable Robi bipolar and Storz laparoscopic
Primary Outcome Measure Information:
Title
The Primary Endpoint of This Study is Time Difference Between Cauterizing One Side of the Uterine Attachments, From the Round Ligament to the Uterine Artery on One Side, to the Time Detaching the Same Tissues on the Other Side
Description
duration of surgery
Time Frame
Primary outcome study data is collected with the first incision and completed with skin closure at the completion of the surgery.
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 21 to 80 years of age
Scheduled for laparoscopic hysterectomy (prospectively)
Exclusion Criteria:
Under 21 years of age
Known or anticipated malignancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mary B Holloran-Schwartz, MD
Organizational Affiliation
St. Louis University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Saint Louis University
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63117
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
No plan to share data
Learn more about this trial
Disposable Energy Sources and Operating Room Time for Laparoscopic Hysterectomy
We'll reach out to this number within 24 hrs